Octreotide for persistent chylothorax in a pediatric patient [2]

Annals of Pharmacotherapy

Volumn 36, Issue 6, 2002, Pages 1106-1107

  Ottinger, Joseph G ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; LIPID EMULSION; MERCAPTOPURINE; MESNA; METHOTREXATE; OCTREOTIDE; PREDNISONE; PROCARBAZINE; SOMATOSTATIN; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHYLOTHORAX; CLINICAL FEATURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG MECHANISM; HUMAN; LETTER; MALE; NONHODGKIN LYMPHOMA; PARENTERAL NUTRITION; PLEURA EFFUSION; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; INTRAVENOUS DRUG ADMINISTRATION;

CHILD; CHYLOTHORAX; HUMANS; INJECTIONS, INTRAVENOUS; LYMPHOMA, NON-HODGKIN; MALE; OCTREOTIDE;

EID: 0036014084     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A313     Document Type: Letter

References (8)

1. Conservative treatment of postsurgical lymphatic leaks with somatostatin-14
2. Somatostatin in the treatment of chylothorax
3. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin
4. Treatment of persistent postoperative chylothorax with somatostatin
5. Etiology and management of pediatric chylothorax
6. Effect of somatostatin on intestinal absorption of nutrients in the rat
7. The influence of somatostatin on the absorption of triglycerides in partially gastrectomized subjects
8. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs